16 October 2023: Viona launches Acetazolamide Tablets, USP 125 mg and 250 mg
31 July 2023: Viona launches Febuxostat Tablets, 40 mg and 80 mg
31 July 2023: Viona launches Sucralfate Tablets, USP 1 gram
Viona Pharmaceuticals is a fast-growing generic pharmaceutical company with its headquarters in Cranford, NJ. Viona is a wholly owned indirect subsidiary of Zydus Lifesciences Limited, a fully integrated, global healthcare provider.
Learn More About Us16 October 2023: Viona launches Acetazolamide Tablets, USP 125 mg and 250 mg
31 July 2023: Viona launches Febuxostat Tablets, 40 mg and 80 mg
31 July 2023: Viona launches Sucralfate Tablets, USP 1 gram